Case Report

Rheumatoid Vasculitis Treated with Infliximab

A. EGON van der BIJL, CORNELIA F. ALLAART, JEROEN P.P. van VUGT, SJOERD G. van DUINEN, and FERDINAND C. BREEDVELD

ABSTRACT.

We describe a patient with rheumatoid vasculitis (RV) who showed a good response to anti-tumor necrosis factor-a therapy. TNF-a antagonists should be considered as treatment in systemic RV, especially in patients who do not respond to immunosuppressive drugs or who have contraindication for such treatment. (J Rheumatol 2005;32:1607-9)

Key Indexing Terms:

RHEUMATOID VASCULITIS
INFLIXIMAB

---

From the Department of Rheumatology, Department of Neurology, and Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands.

Dr. Allaart and Dr. Breedveld have been investigators in sponsor-supported trials with infliximab.

A.E. van der Bijl, MD; C.F. Allaart, MD; J.P.P. van Vugt, MD; S.G. van Duinen, MD; F.C. Breedveld, MD.

Address reprint requests to Dr. A.E. van der Bijl, Department of Rheumatology, Leiden University Medical Centre, Postbus 9600, 2300 RC Leiden, The Netherlands. E-mail: a.e.van_der_bijl@lumc.nl

Accepted for publication March 22, 2005.

---